News
Despite a 40% share price drop since April 2024, CDW's diverse portfolio and high ROE remain strong, outperforming sector ...
SAP (SAP) shares rose 5% in late trading on Tuesday after the German software maker reported first-quarter results that ...
He delivers data-driven insights that empower investors to make well-informed financial decisions. Muslim is a Chartered Certified Accountant (ACCA), a Fellow Member of ACCA Global, and holds a ...
In the bond market, U.S. Treasury yields continued to move in a mixed direction. The shorter-end U.S. 2-Year Treasury yield ( US2Y) advanced 4 basis points to 3.81%, while the U.S. 10-Year Treasury ...
Crypto assets are seeing inflows as investors seek hedging and diversification opportunities and explore ways to capitalize ...
Abercrombie faces demand challenges as consumer sentiment weakens. Read why I rate ANF a sell for the time being.
Medpace Holdings, Inc. ( NASDAQ: MEDP) Q1 2025 Earnings Conference Call April 22, 2025 9:00 AM ET Lauren Morris - Director, Investor Relations August Troendle - Chief Executive Officer Jesse Geiger - ...
Hercules Capital faces challenges as its premium to NAV may dwindle amid looming economic downturns. Learn more on HTGC stock ...
Aurora Innovation's stock is under pressure due to the uncertainty created by tariffs and a looming commercialization ...
Illinois Tool Works Inc.'s Q1 '25 earnings focus on margins, tariffs, and guidance amid economic uncertainty. Read more on ITW and its upcoming data.
Gulfport Energy and Magnolia Oil & Gas initiated with Buy ratings at UBS, while Matador Resources and Comstock Resources started at at Neutral ...
Enliven Therapeutics is a clinical-stage concern that has two candidates in its pipeline targeting oncology indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results